Edward J. Sitar - 15 Dec 2022 Form 4 Insider Report for Timber Pharmaceuticals, Inc.

Role
Director
Signature
/s/ Joseph Lucchese, Power of Attorney
Issuer symbol
N/A
Transactions as of
15 Dec 2022
Net transactions value
+$4,072
Form type
4
Filing time
16 Dec 2022, 15:05:26 UTC
Previous filing
19 Apr 2022
Next filing
18 Apr 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMBR Common Stock, par value $0.001 per share Award $4,072 +2,500 +76% $1.63 5,800 15 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 750 restricted stock units that are unvested.

Remarks:

The shares reported on this Form 4 have been adjusted to reflect the Issuer's 1-for-50 reverse stock split of its common stock, effective November 8, 2022.